Long-term bowel function following delayed coloanal anastomosis: Analysis of a multicentric cohort study (GRECCAR)

IF 2.9 3区医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Colorectal Disease Pub Date : 2025-02-04 DOI:10.1111/codi.70013

Maxime K. Collard, Jean-Jacques Tuech, Charles Sabbagh, Amine Souadka, Jérome Loriau, Eric Rullier, Frédéric Marchal, Adeline Germain, Stéphane Benoist, Jean-Luc Faucheron, Gilles Manceau, Anne Dubois, Anaïs Laforest, Isabelle Sourrouille, Aurore Protat, Diane Mège, Zaher Lakkis, Michel Prudhomme, Simon Derieux, Mehdi Ouaissi, Aurélien Venara, Cécile Brigand, Bernard Lelong, Karine Pautrat, Leon Maggiori, Gil Lebreton, Philippe Rouanet, Marc Pocard, Emilie Duchalais, Quentin Denost, Yann Parc, Jérémie H. Lefevre, for the GRECCAR Group

{"title":"Long-term bowel function following delayed coloanal anastomosis: Analysis of a multicentric cohort study (GRECCAR)","authors":"Maxime K. Collard, Jean-Jacques Tuech, Charles Sabbagh, Amine Souadka, Jérome Loriau, Eric Rullier, Frédéric Marchal, Adeline Germain, Stéphane Benoist, Jean-Luc Faucheron, Gilles Manceau, Anne Dubois, Anaïs Laforest, Isabelle Sourrouille, Aurore Protat, Diane Mège, Zaher Lakkis, Michel Prudhomme, Simon Derieux, Mehdi Ouaissi, Aurélien Venara, Cécile Brigand, Bernard Lelong, Karine Pautrat, Leon Maggiori, Gil Lebreton, Philippe Rouanet, Marc Pocard, Emilie Duchalais, Quentin Denost, Yann Parc, Jérémie H. Lefevre, for the GRECCAR Group","doi":"10.1111/codi.70013","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Aim</h3>\n \n <p>Alteration of bowel function after delayed coloanal anastomosis (DCAA) might be a limitation to its utilization. Our aim was to assess the long-term bowel function of DCAA in a large multicentric cohort.</p>\n </section>\n \n <section>\n \n <h3> Method</h3>\n \n <p>All patients who underwent DCAA interventions at 29 GRECCAR-affiliated hospitals between 2010 and 2021 were retrospectively included. Low anterior resection syndrome (LARS) score or confection of a stoma due to poor bowel function was assessed in eligible patients. Good bowel function was defined by the preservation of bowel continuity with no LARS or a minor LARS.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Among the 385 eligible patients to assess long-term bowel continuity, 63% (<i>n</i> = 243) responded to the questionnaire or had a definitive stoma because of poor bowel function. After a median follow-up of 32 months, good bowel function was reported by 60% (<i>n</i> = 146) of patients (with no LARS 36% and minor LARS 24%), whereas 40% of patients (<i>n</i> = 146) had a poor bowel function including major LARS (36%) and definitive stoma due to poor bowel function (4%). No variables tested were predictive of a poor bowel function after DCAA, including a history of pelvic radiotherapy (<i>P</i> = 0.722), salvage DCAA after failure of a previous anastomosis (<i>P</i> = 0.755), presence of a diverting stoma (<i>P</i> = 0.556), occurrence of an anastomotic leakage (<i>P</i> = 0.416) and time interval from the DCAA to the bowel function assessment (<i>P</i> = 0.350).</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>No LARS or minor LARS was reached for 60% of patients after DCAA. Less than 5% of patients received a definitive stoma due to a poor bowel function.</p>\n </section>\n </div>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"27 2","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2025-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/codi.70013","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Colorectal Disease","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/codi.70013","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Aim

Alteration of bowel function after delayed coloanal anastomosis (DCAA) might be a limitation to its utilization. Our aim was to assess the long-term bowel function of DCAA in a large multicentric cohort.

Method

All patients who underwent DCAA interventions at 29 GRECCAR-affiliated hospitals between 2010 and 2021 were retrospectively included. Low anterior resection syndrome (LARS) score or confection of a stoma due to poor bowel function was assessed in eligible patients. Good bowel function was defined by the preservation of bowel continuity with no LARS or a minor LARS.

Results

Among the 385 eligible patients to assess long-term bowel continuity, 63% (n = 243) responded to the questionnaire or had a definitive stoma because of poor bowel function. After a median follow-up of 32 months, good bowel function was reported by 60% (n = 146) of patients (with no LARS 36% and minor LARS 24%), whereas 40% of patients (n = 146) had a poor bowel function including major LARS (36%) and definitive stoma due to poor bowel function (4%). No variables tested were predictive of a poor bowel function after DCAA, including a history of pelvic radiotherapy (P = 0.722), salvage DCAA after failure of a previous anastomosis (P = 0.755), presence of a diverting stoma (P = 0.556), occurrence of an anastomotic leakage (P = 0.416) and time interval from the DCAA to the bowel function assessment (P = 0.350).

Conclusions

No LARS or minor LARS was reached for 60% of patients after DCAA. Less than 5% of patients received a definitive stoma due to a poor bowel function.

Abstract Image

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

求助全文

约1分钟内获得全文去求助

来源期刊

Colorectal Disease 医学-胃肠肝病学

CiteScore

6.10

自引率

11.80%

发文量

406

审稿时长

1.5 months

期刊介绍： Diseases of the colon and rectum are common and offer a number of exciting challenges. Clinical, diagnostic and basic science research is expanding rapidly. There is increasing demand from purchasers of health care and patients for clinicians to keep abreast of the latest research and developments, and to translate these into routine practice. Technological advances in diagnosis, surgical technique, new pharmaceuticals, molecular genetics and other basic sciences have transformed many aspects of how these diseases are managed. Such progress will accelerate. Colorectal Disease offers a real benefit to subscribers and authors. It is first and foremost a vehicle for publishing original research relating to the demanding, rapidly expanding field of colorectal diseases. Essential for surgeons, pathologists, oncologists, gastroenterologists and health professionals caring for patients with a disease of the lower GI tract, Colorectal Disease furthers education and inter-professional development by including regular review articles and discussions of current controversies. Note that the journal does not usually accept paediatric surgical papers.